Answers are grounded in this paper and cite their sources.
We report the case of an 8-year-old boy who developed a distinctive skin eruption after oral treatment with risperidone for the syndrome of attention deficiency with hyperactivity. The clinical findings were compatible with so-called symmetrical drug related intertriginous and flexural exanthema, also known as Baboon syndrome. Although epicutaneous patch testing with the offending drug was negative, drug rechallenge produced a recurrence of the skin findings. To the best of our knowledge, this is the first case of symmetrical drug related intertriginous and flexural exanthema reported due to risperidone.
No takes yet. Share an insight, caveat, or question.
Akay et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: